Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy

HIGHLIGHTS

• who: Ni Zhao from the University of Kansas Medical Center, United States have published the article: Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy, in the Journal: (JOURNAL)
• what: The authors explored the biomarkers associated with clinical benefits such as tumor response and onset of irAEs. The aim of the study was to investigate whether a defined cytokine panel (IL-1b, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12, IL-17, IFN-a, IFN-g, TNF-a) can . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.